Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
ASCO 2017 - Acute Myeloid Leukemia
A Randomized Phase 2 Study Evaluating Idarubicin and Cytarabine with Clofarabine or Fludarabine in Adults with Newly Diagnosed AML
Read More
ASCO 2017 - Acute Myeloid Leukemia
Unsupervised Hierarchical Clustering of Surface Antigen Expression to Identify Patients with Normal Karyotype AML with Distinct Disease Characteristics and Poor Outcome
Read More
ASCO 2017 - Acute Myeloid Leukemia
Improved Survival with Fludarabine and Timed Sequential Busulfan Regimen in Older Patients with AML or MDS
Read More
ASCO 2017 - Acute Myeloid Leukemia
Allogeneic Transplant Leads to Markedly Improved Survival in Older Patients with Acute Myeloid Leukemia
Read More
ASCO 2017 - Acute Myeloid Leukemia
Nivolumab with Azacytidine in Patients with Relapsed AML
Read More
ASCO 2017 - Acute Myeloid Leukemia
,
Conference Correspondent
Suboptimal Adherence to Guideline-Recommended Molecular Testing in Patients with Newly Diagnosed AML: Data from the Connect MDS/AML Disease Registry
Read More
ASCO 2017 - Acute Myeloid Leukemia
Effect of Cytarabine/Anthracycline/Crenolanib Induction on MRD in Newly Diagnosed FLT3 Mutant AML
Read More
Prostate Cancer
A Multidisciplinary Approach to the Treatment of Prostate Cancer: Providing Therapies That Improve Overall Survival and Quality of Life
Read More
FDA Approvals
Zejula a New Maintenance Treatment Option for Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Read More
Case Study
,
Practice Management
Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plan’s Perspective
Uche Anadu Ndefo, PharmD, BCPS; Rolicia Norman, PharmD; Andrea Henry, PharmD, MBA
Stakeholder Perspective
The Benefits of and Needs for Academic Detailing
Jack E. Fincham, PhD, RPh
Read More
87
88
89
90
91
92
93
Page 90 of 244
Results 891 - 900 of 2434